Biçer Cihangir, Ünalan Esra Nur, Aksu Recep, Önal Ömer, Güneş Işın
Erciyes University, Medical Faculty, Anesthesiology and Reanimation Department, Kayseri, Turquia.
Erciyes University, Medical Faculty, Anesthesiology and Reanimation Department, Kayseri, Turquia.
Braz J Anesthesiol. 2019 Mar-Apr;69(2):144-151. doi: 10.1016/j.bjan.2018.11.002. Epub 2019 Jan 18.
Thoracic paravertebral blockade is an alternative regional technique for comforting post-thoracotomy pain, thereby decreasing opioid consumption, postoperative nausea and vomiting, dizziness, respiratory depression and health care costs. The objective of this study was to investigate the effects of bupivacaine and bupivacaine plus dexmedetomidine on postoperative pain score and analgesic consumption in thoracotomy patients who had undergone ultrasonography-guided paravertebral blockade.
93 ASA I–II patients aged 18–65 years were included in the study and scheduled for thoracic surgery. Prior to anesthesia induction, the paravertebral blockade procedure was performed by an anesthetist with ultrasonography. Cases were randomly stratified into three groups. The paravertebral blockade procedure was performed with 20 mL 0.5% bupivacaine injection in Group B ( = 31) and 20 mL 0.5% bupivacaine + 1 mL dexmedetomidine (100 μg) injection in Group BD. Group C received postoperative i.v. morphine via patient-controlled analgesia without paravertebral blockade. Post-operative pain scores were recorded in the recovery room and post-operatively using a VAS. Hemodynamic parameters, adverse effects and morphine consumption were also recorded.
No significant difference was determined between Group B and Group C regarding intra-operative adverse effects such as bradicardia and hypotension, while these adverse effects were significantly higher in Group BD ( = 0.04). VAS scores with rest and upon movement were significantly lower in Group BD compared to Group C ( < 0.001). Total morphine consumption was significantly lower in both Group B and Group BD in comparison with Group C ( < 0.001). In Group BD, HR and MAP were lower, but this was not clinically significant ( < 0.05).
The addition of dexmedetomidine to bupivacaine lowers postoperative pain scores and morphine consumption in thoracotomy patients who receive ultrasonography guided paravertebral blockade.
胸段椎旁阻滞是一种替代性区域技术,用于缓解开胸术后疼痛,从而减少阿片类药物的使用、术后恶心呕吐、头晕、呼吸抑制及医疗费用。本研究的目的是调查布比卡因和布比卡因加右美托咪定对接受超声引导下椎旁阻滞的开胸手术患者术后疼痛评分及镇痛药物消耗量的影响。
93例年龄在18至65岁之间的美国麻醉医师协会(ASA)I-II级患者纳入本研究并计划行胸科手术。麻醉诱导前,由麻醉医师采用超声进行椎旁阻滞操作。病例随机分为三组。B组(n = 31)采用20 mL 0.5%布比卡因注射液进行椎旁阻滞操作,BD组采用20 mL 0.5%布比卡因 + 1 mL右美托咪定(100 μg)注射液进行椎旁阻滞操作。C组未行椎旁阻滞,术后通过患者自控镇痛静脉给予吗啡。在恢复室及术后使用视觉模拟评分法(VAS)记录术后疼痛评分。还记录了血流动力学参数、不良反应及吗啡消耗量。
B组和C组在术中诸如心动过缓和低血压等不良反应方面无显著差异,而BD组这些不良反应显著更高(P = 0.04)。与C组相比,BD组静息及活动时的VAS评分显著更低(P < 0.001)。与C组相比,B组和BD组的总吗啡消耗量均显著更低(P < 0.001)。在BD组,心率(HR)和平均动脉压(MAP)较低,但无临床意义(P < 0.05)。
在接受超声引导下椎旁阻滞的开胸手术患者中,布比卡因加用右美托咪定可降低术后疼痛评分及吗啡消耗量。